Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis

Authors

S Rule
M Dreyling
A Goy
G Hess
et al

DOI

10.3324/haematol.2018.205229

Publication Date

2019-05-01

Publication Title

Haematologica

Volume

104

Issue

5

Publisher

Ferrata Storti Foundation (Haematologica)

ISSN

1592-8721

Embargo Period

2024-11-19

First Page

e211

Last Page

e214

Recommended Citation

Rule, S., Dreyling, M., Goy, A., Hess, G., & et al. (2019) 'Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis', Haematologica, 104(5), pp. e211-e214. Ferrata Storti Foundation (Haematologica): Available at: https://doi.org/10.3324/haematol.2018.205229